Regulatory Roundup: FDA and FTC Issue Joint Warning Letter on H1N1 Products

October 22, 2009
Pharmaceutical Technology Editors

ePT--the Electronic Newsletter of Pharmaceutical Technology

The two agencies issued a joint Warning Letter to the owners of a website selling unapproved products intended to treat the swine flu virus.

The US Food and Drug Administration and Federal Trade Commission issued a joint Warning Letter on Oct. 19, 2009, to a website offering fraudulent supplements that claim to help prevent the spread of the swine-flu virus, according to an FDA release. The website was asked to cease the fraudulent marketing and advise the agencies of its plan to discontinue fraudulent marketing within 48 hours of receiving the letter. FDA and FTC also asked consumers to be cautious of “promotions or Internet sites offering products for sale that claim to diagnose, prevent, mitigate, treat or cure the 2009 H1N1 influenza virus.”